ORCID as entered in ROS

Select Publications
2024, 'Copper chelation overcomes the immunosuppressive neuroblastoma microenvironment to potentiate anti-GD2 antibody therapy', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 84, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2024 - 10 April 2024, http://dx.doi.org/10.1158/1538-7445.AM2024-2673
,2024, 'Unraveling a prognostic and predictive 8-gene signature related to cuproplasia in pan-cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 84, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2024 - 10 April 2024, http://dx.doi.org/10.1158/1538-7445.AM2024-4942
,2024, 'Abstract 882: Harnessing single cell multi-omics data to identify predictors of clinical outcome in CD19 CAR T cell therapy', in Cancer Research, American Association for Cancer Research (AACR), Vol. 84, pp. 882 - 882, http://dx.doi.org/10.1158/1538-7445.am2024-882
,2020, 'GENOMIC ANALYSIS OF B CELLS PRODUCING PATHOGENIC RHEUMATOID FACTORS', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 50, pp. 47 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000553988700131&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Accumulation of deleterious passenger mutations is associated with the progression of hepatocellular carcinoma', in PLoS ONE, Vol. 11, http://dx.doi.org/10.1371/journal.pone.0162586
,2015, 'Deleterious passenger mutations as a marker for progression towards liver cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 30, pp. 4 - 5, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364505900010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,